CTLA4 and cancer: These may comprise physical or mechanical barriers created by TME combined with different initiating cell types, including cancer-associated fibroblasts (CAFs) and matricellular collagen types, or functional barriers created by immunosuppressive molecules including PD-L1, LAG-3, CTLA-4, and VISTA 1 (23).